8-K: INVO Fertility Restructures Debt, Extends Registration

INVO Fertility, Inc. announced an amendment and exchange of a senior secured convertible debenture, reducing its principal amount by $1.3 million in exchange for preferred stock, and extended key SEC registration deadlines.

Summary

• INVO Fertility, Inc. and Five Narrow Lane LP (FNL) entered into an Amendment and Exchange Agreement and a Side Letter Agreement, both effective August 21, 2025.
• The existing Amended and Restated Senior Secured Convertible Debenture was exchanged for a Second Amended and Restated Senior Secured Convertible Debenture due February 11, 2026.
• The outstanding principal amount of the debenture was decreased to $1,751,343.75.
• FNL received 325 shares of additional Series C-2 Preferred Stock with an aggregate stated value of $1,300,000 in exchange for a $1,300,000 reduction in the debenture's principal.
• The debenture carries a 7% annual interest rate and a conversion price of $1.4765 per share, with a maturity date of February 11, 2026.
• The Company extended the deadline to file a registration statement for resale of FNL's shares (from the debenture, C-2 Preferred Stock, and warrants) to August 29, 2025.
• The deadline for the registration statement to become effective was extended to September 30, 2025 (or October 31, 2025, if subject to full SEC review).

Sentiment

Score: 6

Explanation: The debt principal reduction is a positive step for the company's balance sheet, but it comes with potential future dilution from convertible preferred stock. The extensions for registration deadlines suggest ongoing administrative efforts, and the mandatory redemption clause on future financings adds a layer of caution. Overall, the filing indicates active management of financial obligations and regulatory compliance, with both positive and potentially challenging aspects.

Positives

• The outstanding principal amount of the debenture was reduced by $1,300,000, converting debt into preferred equity, which improves the company's debt profile.
• Extensions for the registration statement filing and effectiveness deadlines provide the company with more time to comply with regulatory requirements for FNL's securities.

Negatives

• The issuance of additional Series C-2 Preferred Stock, which is convertible into common stock, introduces potential future dilution for existing common shareholders.
• The debenture still carries a 7% annual interest rate, and a 15% default interest rate, which is relatively high.
• The company cannot prepay the debenture without FNL's prior written consent, limiting its financial flexibility.
• A mandatory redemption clause requires the company to apply one-third of gross proceeds from future equity or debt financings exceeding $3,000,000 (excluding public offerings) towards debenture redemption, potentially diverting capital from growth initiatives.

Risks

• Dilution Risk: Conversion of the Second Amended and Restated Debenture and Series C-2 Preferred Stock into common stock could dilute the ownership of existing common shareholders.
• Liquidity Risk: The mandatory redemption clause tied to future financings could strain the company's liquidity if a significant portion of new capital must be used for debt repayment.
• Default Risk: Failure to meet debenture obligations (e.g., principal or interest payments, timely share delivery upon conversion, or other covenants) could trigger an Event of Default, leading to immediate repayment at a higher interest rate of 15% per annum.
• Regulatory Compliance Risk: Failure to meet the extended registration statement filing and effectiveness deadlines could result in penalties or further regulatory issues.
• Beneficial Ownership Limitation: The 9.99% conversion limitation for FNL could impact FNL's ability to fully convert its holdings if the company's stock price fluctuates significantly or if the number of outstanding shares changes.

Future Outlook

The company is actively managing its capital structure by restructuring debt and converting a portion into preferred equity. It is also working to ensure the liquidity of its securities held by FNL by extending deadlines for filing and achieving effectiveness of a resale registration statement. This indicates an ongoing effort to optimize its financial position and comply with regulatory requirements.

Industry Context

na

Related Party Transactions

• The Amendment and Exchange Agreement and Side Letter Agreement were entered into with Five Narrow Lane LP (FNL), a significant holder of the company's debt and equity. This constitutes a related party transaction.
• The exchange of the Amended and Restated Debenture for the Second Amended and Restated Debenture with FNL.
• The issuance of 325 shares of additional Series C-2 Preferred Stock to FNL in exchange for a $1,300,000 principal reduction.
• The extension of registration deadlines for FNL's securities.

Stakeholder Impact

• Shareholders: Potential for dilution from the conversion of Series C-2 Preferred Stock and the debenture. The debt reduction could be viewed positively as it reduces financial leverage.
• Creditors (FNL): FNL's debt principal is reduced, but they receive preferred stock, maintaining an investment in the company. Their conversion rights are maintained, and registration deadlines are extended to facilitate liquidity.
• Company: Improved debt profile through principal reduction. Extended deadlines provide more time for regulatory compliance. However, future capital raises may be partially diverted to debt redemption, and the inability to prepay without FNL's consent limits flexibility.

Next Steps

• File the registration statement for resale of FNL's shares by August 29, 2025.
• Cause the registration statement to become effective by September 30, 2025 (or October 31, 2025, if subject to full SEC review).
• File a resale registration statement for New Warrant Shares by August 29, 2025, and use commercially reasonable efforts to cause it to become effective within 90-120 days after Stockholder Approval.
• Continue to comply with all covenants and obligations under the Second Amended and Restated Debenture, including interest payments and potential mandatory redemptions.

Key Dates

Recommendation

While the debt principal reduction is a positive step for INVO Fertility's balance sheet, the issuance of convertible preferred stock introduces potential future dilution. The extensions for registration deadlines suggest ongoing administrative efforts, and the mandatory redemption clause on future financings could impact capital allocation. Given these mixed signals, a 'hold' recommendation is appropriate, advising investors to monitor the company's execution on its registration obligations and its financial performance post-restructuring.

Keywords

INVO Fertility, Five Narrow Lane LP, convertible debenture, debt restructuring, Series C-2 Preferred Stock, SEC registration, equity financing, debt financing, dilution, corporate governance, IVF, NAYA Therapeutics